string(157) "/en/component/flexicontent/item/505-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505"
English
string(160) "/es/component/flexicontent/item/2431-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505-2"
Español
string(157) "/en/component/flexicontent/item/505-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505"
English
string(160) "/es/component/flexicontent/item/2431-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505-2"
Español
string(157) "/en/component/flexicontent/item/505-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505"
English
string(160) "/es/component/flexicontent/item/2431-aaps-2010-application-of-qbd-principles-to-the-formulation-of-er-propranolol-hydrochloride-hydrophilic-matrix-tablets-505-2"
Español